Characteristics of children with Kawasaki disease requiring intensive care: 10 years' experience at a tertiary pediatric hospital  by Kuo, Ching-Chia et al.
+ MODEL
Journal of Microbiology, Immunology and Infection (2016) xx, 1e7Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.e- jmii .comORIGINAL ARTICLECharacteristics of children with Kawasaki
disease requiring intensive care: 10 years’
experience at a tertiary pediatric hospital
Ching-Chia Kuo a, Yu-Shin Lee a, Ming-Ru Lin, Shao-Hsuan Hsia,
Chih-Jung Chen, Cheng-Hsun Chiu, Mao-Sheng Hwang*,
Yhu-Chering Huang*Department of Pediatrics, Chang Gung Children’s Hospital and Chang Gung Memorial Hospital, Chang
Gung University College of Medicine, Taoyuan, TaiwanReceived 4 March 2016; received in revised form 25 May 2016; accepted 27 June 2016






Taiwan* Corresponding authors. Departmen
Street, Guishan District, Taoyuan City
E-mail addresses: hms3013@cgmh.
a These two authors equally contrib
Please cite this article in press as: K
experience at a tertiary pediatric
j.jmii.2016.06.004
http://dx.doi.org/10.1016/j.jmii.2016
1684-1182/Copyright ª 2016, Taiwan S
BY-NC-ND license (http://creativecomAbstract Background/Purpose: Kawasaki disease (KD) is a febrile systemic vasculitis, and
some patients may develop serious complications requiring intensive care. We aim to ascertain
the clinical presentations and outcomes of these patients.
Methods: From October 2004 to October 2014, children with KD who had stayed in the pe-
diatric intensive care unit (ICU) for acute stage treatment were defined as case patients;
for each case, three age/sex-matched patients with KD but without ICU stay, if identified,
were selected as control patients. Clinical data were retrospectively collected and
analyzed.
Results: Among the total of 1065 KD patients, we identified 26 case patients and 71 controls
for statistical analysis. ICU patients had a longer fever duration, and tended to have hemo-
globin level < 10 g/dL, platelet count < 150  109/L, band cell percentage > 10%, peak
serum C-reactive protein level > 200 mg/L, serum albumin value < 3 g/dL, and often pre-
sented with multiorgan system involvement. Time from symptom onset to the diagnosis of
KD was similar between the two groups, but ICU patients were less likely to have KD as a
leading admission diagnosis. Shock (73.1%, n Z 19) was the most common reason for ICU
admission. ICU patients were more likely to receive antibiotics, albumin infusion, and
require a second dose of intravenous immunoglobulin or steroid therapy. No in-hospital
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organ involvement, abnormal hematological and biochemistry biomarkers, KD recognition
difficulty at the time of admission, and intravenous immunoglobulin-refractory KD.
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Kawasaki disease (KD) is an acute febrile vasculitis that
mainly affects medium-sized vessels at the systemic level;
its etiology remains unclear. Intravenous immunoglobulin
(IVIG) and aspirin are the treatment of choice to lower the
risk of coronary artery lesion (CAL) formation. If left un-
treated, KD may result in coronary artery aneurysms in
15e25% of patients,1 and, although rarely, might further
develop into fatal myocardial infarction. The reported case-
fatality rate is low,2 and most deaths occur within
1e2 months of onset.3,4 Several studies have reported the
features of KD shock syndrome (KDSS) over the past few
years in North America and Taiwan,5e8 which included dif-
ficulty for early recognition, delay of treatment, and
increased need for IVIG retreatment. In addition to KDSS,
we encountered a group of children with KD who did not
develop hemodynamic instability in the acute stage but still
required intensive care in the critical care settings. There-
fore, we conducted a caseecontrol study to delineate the
characteristics of children with KD requiring intensive care.Methods
Hospitalized pediatric patients with Kawasaki disease
were selected by discharge code in charts (International
Classification of Diseases, 9th Revision, Clinical Modification
code 446.1) from October 1, 2004 to October 1, 2014
at the Chang Gung Children’s Hospital, Linkou, Taiwan. De-
mographic data and clinical characteristics were collected
via retrospective electronic medical records reviewed inde-
pendently by two pediatric infectious disease specialists.
Those who had been admitted to the intensive care unit
(ICU) during their hospital stay were categorized as ICU
case patients. Patients were excluded if any of the
following conditions was met: underlying primary immu-
nodeficiency diseases receiving immunoglobulin therapy;
conditions requiring systemic corticosteroid administration
for more than 4 weeks; evidence of bacterial growth from
sterile sites; concomitant illness with a diagnosis other than
Kawasaki disease during the same hospitalization; or ICU
admission resulting from conditions other than the acute,
direct impacts of Kawasaki disease. Conditions requiring
ICU admission were categorized by the Guidelines for
Developing Admission and Discharge Policies for the Pedi-
atric Intensive Care Unit. Controls were selected from pa-
tients who had a discharge diagnosis of Kawasaki disease
but were not admitted to the ICU. Three control patients, if
achievable, were identified for each case patient matched
by sex and age (within 3 months of range).uo C-C, et al., Characteristics of
hospital, Journal of MicrobiologyElectronic medical records of enrolled ICU cases and
control patients were reviewed retrospectively to collect the
following data: demographic data (age, sex, admission sea-
son, and days of fever prior to admission); laboratory test
results (white blood cell count, hemoglobin, platelet count,
percentage of neutrophil, percentage and count of band
cell, C-reactive protein, aspartate aminotransferase,
alanine transaminase, blood urea nitrogen, creatinine, and
albumin); clinical information (overall duration of fever,
days of hospitalization, tentative diagnosis at presentation,
time to documented diagnosis of Kawasaki disease, and time
to IVIG therapy); treatments (empiric antibiotics, aspirin,
IVIG, adjuvant corticosteroids, albumin transfusion, and
inotropic agents), and echocardiogram findings (measure-
ments of coronary artery lesions and time to recovery from
coronary artery lesions). The day of fever onset was defined
as Day 0. Spring months were defined as FebruaryeApril,
summer months were defined as MayeJuly, and so on.
Diagnosis of complete or incomplete Kawasaki disease was
classified based on the published standard clinical criteria.
Measurements of CALs were performed by pediatric cardi-
ologists according to the standard of the Japanese Ministry of
Health criteria. Acute stage was defined as 0e10 days after
disease onset, subacute stage as 11e21 days, convalescent
stage as 22e90 days, and chronic stage as 91e365 days. For
patients admitted after July 2014 and who were applied with
Z-score calculation according to the department policy, we
retrospectively reassessed CALs based on documented cor-
onary artery diameter measurements of the time because
the height records for Z-score calculation were not docu-
mented in some of the earlier patients.
We conducted Student t tests to compare means of
continuous variables andChi-square analysis for proportional
differences. ManneWhitney U test was used for comparing
medians in skewed continuous variables. Data analyses were
performed using SPSS software version 20.0 (SPSS Inc., Chi-
cago, IL, USA). A p value < 0.05 was considered statistically
significant. This retrospective study was approved by the
Institutional Review Board of Chang Gung Medical Founda-
tion, Taoyuan, Taiwan (reference number: 103-5514B).
Results
During a 10-year period from October 1, 2004 to October 1,
2014, a total of 1065 patients were admitted to the Linkou
Chang Gung Children’s Hospital with a discharge diagnosis
of Kawasaki disease, and 30 (2.82%) of these patients had
been admitted to the ICU. The annual rate of hospitalized
KD patient requiring intensive care in these 10 study years
(defined from October to September of the next year)
ranged from 0.93% to 4.44%.children with Kawasaki disease requiring intensive care: 10 years’
, Immunology and Infection (2016), http://dx.doi.org/10.1016/
Figure 1. Events requiring intensive care unit admission
categorized by organ-system. One patient may have presented
with multiorgan system involvement, so the total event num-
ber was greater than the number of intensive care unit pa-
tients. CV Z cardiovascular.
Table 1 Demographics of intensive care unit (ICU) pa-
tients and control patients.
Demographics ICU (n Z 26) Control (n Z 71) p
Male sex (%) 50.0 52.1 0.854
Age (mo)
Mean  SD 32.4  32.1 30.8  30.4 0.819
Median (range) 22 (2e115) 21 (2e115) 0.945
< 12 mo (%) 42.3 35.2 0.522






Table 2 Comparison of clinical characteristics between






Fever duration prior to
admission (d)
3.8  1.6 4.5  2.1 0.065
Median (range) 4 (1e9) 4 (1e10) 0.153
KD as initial diagnosis
(%)
42.3 66.2 0.034
Complete KD (%) 53.8 73.2 0.070
Time from fever onset
to diagnosis (d)
7.0  3.4 7.0  2.4 0.945
Median (range) 5.5 (4e17) 6 (4e17) 0.289
> 10 d (%) 15.4 5.6 0.204




6.1  2.0 6.8  2.1 0.147
Median (range) 5 (4e11) 6 (4e15) 0.072
>10 d (%) 4.2 4.4 > 0.999
Time from admission
to IVIG usage (d)
2.2  1.9 2.4  2.0 0.734
Median (range) 2 (0e8) 2 (0e9) 0.820
Repeated IVIG
usage (%)
37.5 2.9 < 0.001




Antibiotics (%) 92.3 62.0 0.004
Inotropic agents (%) 38.5 0.0 < 0.001




Positive for isolation (%) 5.0 21.4 0.214
IVIG Z intravenous immunoglobulin; KD Z Kawasaki disease.
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+ MODELAll 30 patients with the conditions requiring ICU admis-
sion in this study were system-wise categorized and
demonstrated in Fig. 1. Nineteen of the 21 patients
with cardiovascular insults had documented shock (78.9%,
15/19) or clinical symptoms/signs of impending shock
identified by close monitoring of blood pressure (21.1%, 4/
19), and these 19 patients were defined as KDSS patients.
One patient experienced an episode of supraventricular
tachycardia, and another one received pericardiocentesis.
Two of the four patients with respiratory insults were
intubated and put on mechanical ventilation for 3 days and
7 days, respectively. One of the two patients who devel-
oped acute renal failure required acute hemodialysis. One
of the three patients with gastrointestinal involvement
presented with severe ileus and suspected acute abdomen.
Three of the four patients with hematologic presentations
had severe anemia, hence the consequent compromised
respiratory or hemodynamic status. The other developed
disseminated intravascular coagulation.
After excluding four ICU patients requiring intensive
care as a result of either the indirect impacts of KD or
complications beyond the acute stage, we identified the
remaining 26 ICU patients as case subjects for subsequent
analysis, and 71 corresponding age- and sex-matched pa-
tients without ICU stay were randomly selected as controls.
Demographics
The demographic characteristics of the case and control
patients are shown in Table 1. Half of the ICU patients were
male, and 42% were aged < 1 year. The incidence of both
ICU (34.6%, 9/26) and controls (35.2%, 25/71) was higher
during the summer months. Seven (26.9%) of the 26 ICU
patients were transferred from other medical facilities due
to deteriorated conditions. Four of the seven transferred
patients were admitted to the ICU immediately, while the
other three patients were admitted to the ordinary ward
first. By contrast, only one (5.3%) of the other 19 non-
transfer ICU patients was directly admitted to the ICU at
the first encounter with our own emergency department.Please cite this article in press as: Kuo C-C, et al., Characteristics of
experience at a tertiary pediatric hospital, Journal of Microbiology
j.jmii.2016.06.004Clinical characteristics
Detailed clinical characteristics are shown in Table 2. Both
case group and control group presented a similar duration
of fever at the time of admission. All of the 97 enrolledchildren with Kawasaki disease requiring intensive care: 10 years’
, Immunology and Infection (2016), http://dx.doi.org/10.1016/
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had complete KD, and the proportion was higher in the
controls. However, ICU patients were less likely to have KD
as a leading diagnosis at admission than control patients
(42.3% vs. 66.2%, p Z 0.03). Twelve (46.2%) ICU patients
had KD as one of the tentative diagnoses before transfer,
and two of them developed the impression of KD at the
time of ICU transfer. Two of the three ICU patients with
suspected toxic shock syndrome or severe sepsis received
IVIG therapy before the diagnosis of KD was established.
Therapy with IVIG was administered in a timely manner in
both groups, but ICU cases tended to need a second dose of
IVIG as a result of refractory KD (37.5% vs. 2.9%, p < 0.001),
and even adjuvant steroid treatment. Two (7.7%) of the ICUTable 3 Comparison of laboratory data between intensive care
Laboratory values ICU (n Z 26)
WBC count, 109/L, on admission 14.7  7.2
WBC count, 109/L, peak 20.6  6.9
> 20  109/L (%) 46.2
Hemoglobin, on admission 10.9  1.8
< 10 g/dL (%) 26.9
Hemoglobin, nadir, g/dL 8.6  1.4
Decrease after admission (%) 92.3
< 8 g/dL (%) 34.6
Platelet, 109/L, on admission 241.0  167.4
< 150  103/L (%) 26.9
150e400  109/L (%) 61.5
> 400  109/L (%) 11.5
Decrease after admission (%) 76.9
Decrease to < 150  109/L (%) 65.0
Platelet, 109/L, nadir 167.7  145.8
< 100  109/L (%) 38.5
Platelet, 109/L, peak 528.3  191.9
Segment, % 65.4  17.5
Band, %, on admission 9.0  11.8
> 10 (%) 23.1
Band, count, on admission 1152.1  1559.
> 700 absolute count (%) 42.3
Band, %, peak 15.1  16.6
> 10 (%) 50.0
Band, count, peak 2532.5  3151.
> 700 absolute count (%) 65.4
CRP, mg/L, on admission 162.9  87.0
> 100 mg/L (%) 80.8
CRP, mg/L, peak 201.8  98.2
> 200 mg/L (%) 50.0
AST, IU/L, on admission 56.9  43.1
ALT, IU/L, on admission 65.5  55.3
BUN, mg/dL, on admission 20.5  17.1
Creatinine, mg/dL, on admission 0.6  0.4
> 1 mg/dL, on admission (%) 16.0
Albumin, g/dL, on admission 2.9  0.5
< 3 g/dL, on admission (%) 60.9
Albumin, g/dL, nadir 2.8  0.6
< 2.5 g/dL, nadir (%) 39.1
Albumin infusion (%) 34.6
Pyuria (%) 28.0
ALTZ alanine transaminase; ASTZ aspartate transaminase; BUNZ b
cell.
Please cite this article in press as: Kuo C-C, et al., Characteristics of
experience at a tertiary pediatric hospital, Journal of Microbiology
j.jmii.2016.06.004cases and three (4.2%) of the control patients did
not receive IVIG therapy, and the median duration from
fever onset to KD diagnosis of these five patients was
15 days (range, 9e17 days). Aspirin was not given to three
(11.5%) ICU cases because of prolonged coagulopathy and
anemia. The majority of hospitalized patients were pre-
scribed with antibiotics on admission, especially the
ICU group (92.3% vs. 62.0%, p Z 0.004). One-third of ICU
patients were administered with albumin supplementa-
tions. Inotropic agents including dopamine, dobutamine,
milrinone, or epinephrine were applied alone (80.0%, 8/10)
or in combination to 10 of the 19 shock patients, at the
discretion of clinical physicians.unit (ICU) patients and control patients.
Control (n Z 71) p
14.8  6.0 0.949
16.60  5.9 0.060
25.4 0.050
11.3  0.9 0.311
9.9 0.050
10.5  1.3 < 0.001
52.1 < 0.001
2.8 < 0.001






374.0  141.5 < 0.001
1.4 < 0.001
479.2  175.1 0.237
63.5  14.5 0.593
1.2  2.1 0.002
0.0 < 0.001
2 168.2  345.5 0.004
8.6 < 0.001
1.6  2.1 < 0.001
0.0 < 0.001
6 233.3  374.7 0.001
10.0 < 0.001
111.5  80.9 0.008
48.6 0.005
134.0  85.2 0.001
22.9 0.010
59.7  73.2 0.860
76.4  91.0 0.580
8.7  5.1 0.002
0.4  0.2 0.003
0.0 0.020
3.6  0.6 < 0.001
13.0 0.001




lood urea nitrogen; CRPZ C-reactive protein; WBCZ white blood
children with Kawasaki disease requiring intensive care: 10 years’
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Detailed laboratory values are shown in Table 3. Patients
admitted to the ICU had lower platelet counts (p < 0.001),
higher band cell percentage (p Z 0.002) and counts
(p Z 0.004), higher C-reactive protein (CRP) levels
(p Z 0.008), higher blood urea nitrogen (p Z 0.002) and
creatinine (p Z 0.003) levels, and lower albumin levels
(p < 0.001) at admission. The majority of both case and
control patients had normal platelet counts at the time of
admission. By comparison, initial thrombocytopenia was
disclosed in seven (26.9%) ICU patients, but only one (1.4%)
of the control patients. At extreme values throughout the
hospital stay, the ICU patients were more likely to have
lower nadir hemoglobin levels (p < 0.001), lower nadir
platelet counts (p < 0.001), greater peak band cell per-
centage (p < 0.001) and counts (p Z 0.001), higher peak
CRP levels (p Z 0.001), and lower nadir albumin levels
(p < 0.001). Decrease of hemoglobin levels along the course
of KD was significantly more common in the case patients
(92.3% vs. 52.1%, p < 0.001). Similar decrease in platelet
counts was noticed in the ICU group and reached statistical
significance (76.9% vs. 15.9, p < 0.001). Virus isolation was
performed on 28 (39.4%, 28/71) control patients and turned
out positive in six of them (cytomegalovirus, enterovirus,
herpes simplex virus type 1, parainfluenza virus type 1, and
two patients with adenovirus, respectively), while only one
out of 20 (76.9%, 20/26) tested ICU patient was positive for
enterovirus.Table 4 Comparison of clinical outcomes between







Duration (d) 10.2  6.4 7.1  2.1 0.023
Median (range) 8 (5e31) 7 (4e16) 0.061
Length of stay (d) 12.1  6.5 5.7  2.3 < 0.001




LMCA (%) 50.0 32.9 0.123
LADA (%) 31.8 26.5 0.647
RMCA (%) 34.6 19.7 0.127
Acute stage (%) 44.0 32.9 0.318
Subacute stage (%) 64.3 27.3 0.066
Convalescent stage (%) 25.0 28.1 0.791





Median (range) 2 (1e27) 4.5 (1e23) 0.194
Recurrent KD after
discharge (%)
3.9 2.8 > 0.999
In-hospital mortality (%) 0.0 0.0 > 0.999
CAL Z coronary artery lesion; KD: Kawasaki disease;
LADA Z left anterior descending artery; LMCA Z left main
coronary artery; RMCA Z right main coronary artery.
Please cite this article in press as: Kuo C-C, et al., Characteristics of
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Details of clinical outcomes are shown in Table 4. The pa-
tients admitted to the ICU needed a median of 5 more days
for hospitalization (p < 0.001), and spent a median of
4.5 days (range, 1e9 days) in the ICU. The proportion of ICU
patients developing CAL appeared to be greater than that
of the control patients, but did not reach statistical sig-
nificance. Five patients had ongoing coronary artery dila-
tation by January 1, 2015 based on their latest
echocardiogram results. These patients kept follow-up
visits as instructed at our cardiology outpatient clinic, and
all five patients continued daily low dose aspirin adminis-
tration. Based on the latest echocardiogram measure-
ments, two ICU cases had persistent CAL for at least 60
(with aneurysm formation, 7.1 mm in diameter) and
120 months, and three control patients still had CALs at the
8th, 16th, and 102nd (with aneurysm formation, 8.3 mm in
diameter) months respectively after hospitalization for KD.
There was no in-hospital mortality or death from KD after
discharge. Three (3.1%) patients had experienced recurrent
KD by January 2015, including one patient (3.9%) from the
ICU group and two patients (2.8%) from the control group.Discussion
As the concept of KDSS has become more familiar to pedi-
atricians in the past few years, the reported incidence rate
of KDSS ranges from 2.60% to 6.95% for children in Western
countries.5e7 In this study, 2.44% (26/1065) of the KD pa-
tients required intensive care after four ambiguous cases
were excluded. Composing the overall ICU admission rate,
the incidence of KDSS was 1.78 per 100 KD cases during the
decade we reviewed. A caseecontrol study conducted by
Chen et al8 demonstrated the KDSS rate to be 1.9% among
Taiwanese children with KD, which was similar to our re-
sults. In addition, a large-scaled population-based epide-
miological report in Taiwan also revealed a lower incidence
rate at 1.45%,9 which suggested possible interracial differ-
ences regarding the development of KDSS. However, while
the absence of the Asian KDSS patient in the study by
Kanegaye et al6 seemed to support the hypothetical dif-
ference in ethnicity, a higher incidence rate was not
discovered in the Hispanic population by Ga´mez-Gonza´lez
et al7 in their study of Mexican children. Further analysis
would be needed to clarify the association between
ethnicity and KDSS.
Based on previous epidemiology reports,10,11 KD occurs
in Taiwan most frequently in the summer and least
frequently in the winter. This pattern of distribution was
compatible with the control patients, ICU cases, and those
who developed KDSS in this study. In search of possible
disease-causing infectious agents, virus isolation was per-
formed in 76.9% (20/26) of the ICU cases in this study;
nevertheless, the positive virus isolation rate was low
(5.00%, 1/20). By contrast, the control patients had a
higher positive isolation rate (21.40%, 6/28) although sta-
tistical significance was not reached. Several viruses were
supposed to be associated with KD in Taiwan,12 but our
results did not show a similar picture in either ICU or con-
trol groups. Whether the virus isolated in this studychildren with Kawasaki disease requiring intensive care: 10 years’
, Immunology and Infection (2016), http://dx.doi.org/10.1016/
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certain. Because the virus isolation was applied only in a
smaller proportion (39.4%, 28/71) of the control group at
the clinicians’ discretion, the detection rate and the di-
versity of viruses identified may not be representative of
the general KD population not requiring intensive care. By
contrast, the low positive rate despite more sampling might
suggest a different etiology for patients with more severe
KD. The detection of virus in KD patients admitted to the
ICU should be interpreted with caution, and the correlation
between virus infection and ICU admission warrants further
investigations on a larger scale.
Our 26 ICU patients tended to have alterations in band
cell values, hemoglobin levels, platelet levels, albumin
levels, CRP levels, and resistance to IVIG therapy, which is
consistent with previous reports.5e8 KD patients with ICU
admission generally showed significantly lower platelet
levels at both admission and nadir value in the study by
Dominguez et al,5 which was echoed by Chen et al8 showing
lower initial platelet levels in shock patients. This finding
was of particular interest to us because our ICU patients
were not only more likely to have lower platelet values but
also had a tendency to experience a decline in platelet
counts after admission (p < 0.001). Furthermore, the ICU
patients with a decline in platelet counts tended to reach a
level of thrombocytopenia < 150  109/L compared with
control patients (65.0% vs. 0%, p Z 0.006). Regarding ICU
patients without hypotension, a similar decline occurred in
57.1% (4/7) of them, and all of the four patients went on
reaching a level of thrombocytopenia < 150  109/L.
Thrombocytopenia in the acute stage has received atten-
tion over recent years, whereas thrombocytosis was
thought to be a feature of later phase.1 Even though the
mechanism remains unclear, early thrombocytopenia is
recognized as a risk factor of coronary aneurysm forma-
tion,1,13 and possibly, for KDSS as well.8 However, the as-
sociation between thrombocytopenia and ICU patient
without KDSS needs additional corroboration.
In addition, it seemed that our ICU patients were more
likely to have compromised renal function. Similar to our
findings, Gatterre et al14 reported renal dysfunction in the
majority of KD patients (10/11) admitted to the ICU.
Several other organ systems including cardiovascular, res-
piratory, neurological, and gastrointestinal were also
involved, and eight (72.7%) of their patients had multiple
organ dysfunction syndrome. We also observed several of
our cases with organ dysfunctions other than shock that
urged intensive care, although hemodynamic instability
remained the main reason for ICU admission in this study. A
20-month-old boy in this study presented with KD and
simultaneous hemophagocytic lymphohistiocytosis (HLH)
was transferred to the ICU due to altered consciousness. To
our knowledge, cases with KD and subsequent HLH have
scarcely been documented in the English literature.15,16
Different from our case, Kang et al16 reported 12 patients
who developed HLH at a median of 12 days following the
initial KD episode. Owing to the overlapping symptoms
between KD and HLH, serial echocardiogram was crucial for
differentiation and diagnosis especially when the two dis-
eases occurred together.15 In view of the fact that the KDSS
incidence rate appeared to be lower in Taiwan compared
with that in Western countries, other rare manifestations asPlease cite this article in press as: Kuo C-C, et al., Characteristics of
experience at a tertiary pediatric hospital, Journal of Microbiology
j.jmii.2016.06.004a result of more severe inflammation required constant
vigilance.
For the four ICU patients excluded for further statistical
analysis, their unusual clinical presentations deserve
further descriptions and may alert clinicians of the addi-
tional possible serious complications of KD. The first patient
was a 6-month-old girl who presented symptoms of bron-
chiolitis without fever on admission, and cardiomegaly was
incidentally disclosed on chest radiography. Following
echocardiogram revealed massive pericardial effusion with
coronary artery dilatation. Complication resulting from
undiagnosed KD 5 weeks earlier was highly suspected, and
the patient was transferred to ICU for pericardiocentesis.
The second patient was a 38-month-old boy experiencing
acute hemolysis 3 days after a second high dose IVIG ther-
apy for refractory KD, which accounted for the rapid
decrease of hemoglobin level from 11.7 g/dL to 4.5 g/dL.
Methylprednisolone pulse therapy was applied and followed
by 7 days of oral prednisolone. The third patient was a 4-
month-old boy suspected to have Reye syndrome after high
dose aspirin therapy with presentations of persistent vom-
iting, encephalopathy, and liver function impairments;
although Reye syndrome was not confirmed since his par-
ents did not agree to a diagnostic tissue biopsy. The fourth
patient was an 8-month-old girl with incomplete KD, who
developed rhabdomyolysis possibly associated with
concomitant norovirus infection. This patient underwent
continuous venovenous hemofiltration for 10 days, and
aspirin was discontinued after normalization of dilated
coronary artery 4 weeks later.
There were several limitations of this study. Firstly, the
concept of KDSS was not well known in the first few years of
our study period, and KDSS patients might have been mis-
diagnosed as toxic shock syndrome,17,18 leading to misclas-
sification. In order to prevent missed cases of KDSS, we
retrospectively reviewed the electronic medical records of
all the other patients with a diagnosis code of shock included
in their discharge records, and none of these shock patients
met the criteria of KD. Secondly, our study was conducted in
a tertiary pediatric hospital in northern Taiwan; the findings
of our cases may not be generalized to patients of other
ethnicities. However, with the third highest incidence of KD
worldwide,11 Taiwan should be considered a credible
representative for Asian countries until publication of new
evidence. Thirdly, the case number of our ICU patients
without KDSS was small, and may not have enough power to
be demonstrative for its uniqueness. Multicenter, interna-
tional, prospective studies may be needed to exhibit a more
complete spectrum of this subgroup.
In conclusion, KDSS predominated the KD patients
requiring ICU admission, but the incidence rate of KDSS in
Taiwan was lower than that of Western countries. A mi-
nority of KD patients without hemodynamic instability may
also require intensive care, but clinical presentations var-
ied. It is important for pediatricians to stay aware of these
more severe forms of KD for early recognition and timely
treatment.Conflicts of interest
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